Adverts

Open Access Articles- Top Results for L-745,870

L-745,870

</th></tr>
L-745,870
File:L-745870 structure.png
Systematic (IUPAC) name
3-([4-(4-chlorophenyl)piperazin-1-yl]methyl)-1H-pyrrolo[2,3-b]pyridine
Clinical data
Identifiers
158985-00-3 7pxY
PubChem CID 5311200
ChemSpider 4470720 7pxN
ChEMBL CHEMBL267014 7pxN
Chemical data
Formula C18H19ClN4
326.822 g/mol
 14pxN (what is this?)  (verify)

L-745,870 is a drug which acts as a dopamine receptor antagonist selective for the D4 subtype, and has antipsychotic effects in animal models, though it was not effective in human trials.[1][2][3]

References

  1. ^ Bristow LJ, Kramer MS, Kulagowski J, Patel S, Ragan CI, Seabrook GR (June 1997). "Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist". Trends in Pharmacological Sciences 18 (6): 186–8. PMID 9226994. doi:10.1016/s0165-6147(97)01066-3. 
  2. ^ Zhang K, Grady CJ, Tsapakis EM, Andersen SL, Tarazi FI, Baldessarini RJ (September 2004). "Regulation of working memory by dopamine D4 receptor in rats". Neuropsychopharmacology 29 (9): 1648–55. PMID 15138447. doi:10.1038/sj.npp.1300491. 
  3. ^ Moustgaard A, Hau J, Lind NM (2008). "Effects of dopamine D4 receptor antagonist on spontaneous alternation in rats". Behavioral and Brain Functions 4: 49. PMC 2577092. PMID 18945334. doi:10.1186/1744-9081-4-49. 


Lua error in package.lua at line 80: module 'Module:Buffer' not found.